Halozyme Therapeutics, Inc. (HALO)
68.52
-0.46
(-0.67%)
USD |
NASDAQ |
May 21, 16:00
68.52
0.00 (0.00%)
After-Hours: 19:59
Halozyme Therapeutics Accounts Payable (Quarterly) : 14.10M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 489.30M |
| Agenus, Inc. | 71.08M |
| Inovio Pharmaceuticals, Inc. | 1.988M |
| Curis, Inc. | 6.742M |
| LadRx Corp. | 1.102M |